Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have engineered changes to the revolutionary CRISPR-Cas9 genome editing system that significantly cut down on “off-target” editing errors. The refined technique addresses one of the major technical issues in the use of genome editing.
The CRISPR-Cas9 system works by making a precisely targeted modification in a cell’s DNA. The protein Cas9 alters the DNA at a location that is specified by a short RNA whose sequence matches that of the target site. While Cas9 is known to be highly efficient at cutting its target site, a major drawback of the system has been that, once inside a cell, it can bind to and cut additional sites that are not targeted. This has the potential to produce undesired edits that can alter gene expression or knock a gene out entirely, which might lead to the development of cancer or other problems. In a paper published today in Science, Feng Zhang and his colleagues report that changing three of the approximately 1,400 amino acids that make up the Cas9 enzyme from S. pyogenes dramatically reduced “off-target editing” to undetectable levels in the specific cases examined.
Zhang and his colleagues used knowledge about the structure of the Cas9 protein to decrease off-target cutting. DNA, which is negatively charged, binds to a groove in the Cas9 protein that is positively charged. Knowing the structure, the scientists were able to predict that replacing some of the positively charged amino acids with neutral ones would decrease the binding of “off target” sequences much more than “on target” sequences.
After experimenting with various possible changes, Zhang’s team found that mutations in three amino acids dramatically reduced “off-target” cuts. For the guide RNAs tested, “off-target” cutting was so low as to be undetectable.
The newly-engineered enzyme, which the team calls “enhanced” S. pyogenes Cas9, or eSpCas9, will be useful for genome editing applications that require a high level of specificity. The Zhang lab is immediately making the eSpCas9 enzyme available for researchers worldwide. The team believes the same charge-changing approach will work with other recently described RNA-guided DNA targeting enzymes, including Cpf1, C2C1, and C2C3, which Zhang and his collaborators reported on earlier this year.
The prospect of rapid and efficient genome editing raises many ethical and societal concerns, says Zhang, who is speaking this morning at the International Summit on Gene Editing in Washington, DC. “Many of the safety concerns are related to off-target effects,” he said. “We hope the development of eSpCas9 will help address some of those concerns, but we certainly don’t see this as a magic bullet. The field is advancing at a rapid pace, and there is still a lot to learn before we can consider applying this technology for clinical use.”
The Latest on: CRISPR-Cas9 genome editing
via Google News
The Latest on: CRISPR-Cas9 genome editing
- Attitudes of clinical geneticists and certified genetic counselors toon July 5, 2019 at 1:27 pm
Genome editing of the human embryo using CRISPR/Cas9 has the potential to prevent hereditary diseases from being transmitted to the next generation. However, attitudes to this technology have not been ... […]
- Scientists cure lab mice of deafness with radical new gene-editing techniqueon July 4, 2019 at 5:49 am
Classic CRISPR-Cas9 gene-editing systems were created from bacteria ... their system managed to spot a single incorrect DNA letter among three billion in the mouse genome. First author Dr Bence Gyorgy ... […]
- Optimized gene-editing tool prevents hearing loss in mice with hereditary deafness without detectable off-target effectson July 3, 2019 at 8:02 am
The new approach, described online July 3 in Nature Medicine, involves an optimized, more precise version of the classic CRISPR-Cas9 gene-editing system that is better at recognizing the disease ... […]
- In a first, scientists eliminate HIV from an animal's genomeon July 3, 2019 at 6:33 am
ART is not a cure for HIV and requires lifelong use. In this study, the researchers used a gene editing system called CRISPR-Cas9 to remove large fragments of HIV DNA from infected cells, along with a ... […]
- For the first time, researchers use gene editing to cure mice of HIVon July 2, 2019 at 4:04 pm
CRISPR-Cas9 is a gene editing tool that’s been hailed as a breakthrough technology ... it’s no longer an infectious disease but becomes a genetic disease, because the viral genome is incorporated into ... […]
- Scientists eliminate HIV in the entire genome of lab mice for the first time everon July 2, 2019 at 4:01 am
Meanwhile, Dr Khalili, a named inventor on patents that cover the coveted gene-editing technology CRISPR-Cas9, was trying to use CRISPR to wipe HIV from the genome of mice - without success. The main ... […]
- Live CRISPR-Cas9 Loaded with Short RNA Deadens Targeted Geneson July 2, 2019 at 3:00 am
Genome engineers have been using catalytically ... whose work on the CRISPR/Cas9 nuclease led to its use as a gene editing tool. The researchers determined that when CRISPR-Cas9 is acting to block ... […]
- University of California awarded new U.S. CRISPR-Cas9 patenton July 1, 2019 at 9:50 pm
UC's growing portfolio now includes patent for genome editing in a cell using ... were included among the CRISPR-Cas9 gene editing technology work disclosed first by the Doudna-Charpentier team ... […]
- CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target siteson June 28, 2019 at 3:13 am
Precise genome editing/correction of DNA double-strand breaks (DSBs) induced by CRISPR-Cas9 by homology-dependent repair (HDR) is limited by the competing error-prone non-homologous end-joining (NHEJ) ... […]
- Gene Editing Techniques: ZFNs, TALENs or CRISPR?on June 28, 2019 at 2:16 am
together with a CRISPR-associated protein (Cas), a genome editing system in bacteria, which functions differently compared to TALENs and ZFNs. Both TALENs and CRISPR-Cas9 are endonucleases that target ... […]
via Bing News